Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value: $121M (100.0% shares, 0.0% debt)

Holdings (25)

SAGE THERAPEUTICS INC 10.9%
Value $13.25M Shares 259,500 Est. Cost $47.85 Unrealized
LOXO ONCOLOGY INC 9.5%
Value $11.56M Shares 360,000 Est. Cost $28.44 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 8.3%
Value $10.04M Shares 240,500 Est. Cost $51.75 Unrealized +1.4%
FOUNDATION MEDICINE INC 8.0%
Value $9.664M Shares 546,000 Est. Cost $18.96 Unrealized
EVH EVOLENT HEALTH INC 6.8%
Value $8.214M Shares 555,000 Est. Cost $18.09 Unrealized +8.9%
BLUEPRINT MEDICINES CORP 5.7%
Value $6.858M Shares 244,500 Est. Cost $26.00 Unrealized
SPARK THERAPEUTICS INC 5.3%
Value $6.412M Shares 128,500 Est. Cost $44.87 Unrealized
GENMARK DIAGNOSTICS INC 5.2%
Value $6.242M Shares 510,000 Est. Cost $9.74 Unrealized
BLUEBIRD BIO INC 4.2%
Value $5.09M Shares 82,500 Est. Cost $60.64 Unrealized
VYGR VOYAGER THERAPEUTICS INC 4.1%
Value $4.905M Shares 385,000 Est. Cost $16.46 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 3.6%
Value $4.393M Shares 304,000 Est. Cost $17.96 Unrealized
KITE PHARMA INC 3.5%
Value $4.215M Shares 94,000 Est. Cost $52.57 Unrealized
MYOKARDIA INC 2.8%
Value $3.432M Shares 265,000 Est. Cost $13.62 Unrealized
EPIZYME INC 2.7%
Value $3.328M Shares 275,000 Est. Cost $14.50 Unrealized
ILMN ILLUMINA INC 2.6%
Value $3.201M Shares 25,000 Est. Cost $134.78 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 2.6%
Value $3.182M Shares 85,000 Est. Cost $61.19 Unrealized -31.6%
CERNER CORP 2.5%
Value $3.079M Shares 65,000 Est. Cost $47.37 Unrealized
MDRX ALLSCRIPTS HEALTHCARE SOLUTN 2.4%
Value $2.859M Shares 280,000 Est. Cost $12.81 Unrealized -11.0%
AMYRIS INC 2.1%
Value $2.5M Shares 3,425,000 Est. Cost $0.73 Unrealized
SYROS PHARMACEUTICALS INC 1.8%
Value $2.215M Shares 182,141 Est. Cost $13.81 Unrealized
AEVI GENOMIC MEDICINE INC 1.6%
Value $1.943M Shares 375,000 Est. Cost $5.18 Unrealized
CTMX CYTOMX THERAPEUTICS INC 1.2%
Value $1.401M Shares 127,500 Est. Cost $15.82 Unrealized -23.4%
ACCELERON PHARMA INC 0.9%
Value $1.148M Shares 45,000 Est. Cost $25.51 Unrealized
EDIT EDITAS MEDICINE INC 0.9%
Value $1.055M Shares 65,000 Est. Cost $20.49 Unrealized -25.9%
GILD GILEAD SCIENCES INC 0.7%
Value $895K Shares 12,500 Est. Cost $53.19 Unrealized 0.0%